These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7718845)

  • 1. Silicotuberculosis: long-term outcome after short-course chemotherapy.
    Cowie RL
    Tuber Lung Dis; 1995 Feb; 76(1):39-42. PubMed ID: 7718845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short course chemoprophylaxis with rifampicin, isoniazid and pyrazinamide for tuberculosis evaluated in gold miners with chronic silicosis: a double-blind placebo controlled trial.
    Cowie RL
    Tuber Lung Dis; 1996 Jun; 77(3):239-43. PubMed ID: 8758107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
    Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silicosis and tuberculosis.
    Morgan EJ
    Chest; 1979 Feb; 75(2):202-3. PubMed ID: 421560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
    Cowie RL; Brink BA
    S Afr Med J; 1990 Apr; 77(8):390-1. PubMed ID: 2184527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-course chemotherapy for silicotuberculosis.
    Escreet BC; Langton ME; Cowie RL
    S Afr Med J; 1984 Sep; 66(9):327-30. PubMed ID: 6382640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
    Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.
    Balasubramanian R; Sivasubramanian S; Vijayan VK; Ramachandran R; Jawahar MS; Paramasivan CN; Selvakumar N; Somasundaram PR
    Tubercle; 1990 Dec; 71(4):253-8. PubMed ID: 2125153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effectiveness of pyrazinamide-containing six-month short course chemotherapy].
    Wada M
    Kekkaku; 2000 Nov; 75(11):665-73. PubMed ID: 11140090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
    Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S; Futsuki Y; Tomari S; Araki J
    Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary tuberculosis in South African gold miners.
    Cowie RL; Langton ME; Becklake MR
    Am Rev Respir Dis; 1989 May; 139(5):1086-9. PubMed ID: 2712435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of regimens containing INH, RFP with varied chemotherapy courses on retreated culture positive pneumoconio-tuberculosis].
    Jiang W; Chen H; Gao J; Huaibei M
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):648-50. PubMed ID: 11477888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
    Pretet S; Grosset J; Perdrizet S
    Bull Int Union Tuberc; 1978 Dec; 53(4):260-1. PubMed ID: 387140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.